Genomtec (WAR:GMT) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genomtec COGS-to-Revenue?

Genomtec's Cost of Goods Sold for the three months ended in Dec. 2023 was zł0.72 Mil. Its Revenue for the three months ended in Dec. 2023 was zł0.00 Mil.

Genomtec's COGS to Revenue for the three months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genomtec's Gross Margin % for the three months ended in Dec. 2023 was %.

Genomtec COGS-to-Revenue Historical Data

The historical data trend for Genomtec's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec COGS-to-Revenue Chart

Genomtec Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

1.80

176.40

24.57

81.78

794.00

Genomtec Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial											132.89	0.48	-	1.00	-

Genomtec COGS-to-Revenue Calculation

Genomtec's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.794	/	0.001
	=	794.00

Genomtec's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.719	/	0
	=

Genomtec (WAR:GMT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genomtec's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.719 / 0
	=	%

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Genomtec COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genomtec's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomtec (WAR:GMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

4VI:Germany

Address

ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066

Website

http://www.genomtec.com

Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines